Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,090,131,227
-$45,658,790 QoQ
Shares Held
43,571,633
-21.2% QoQ
Ownership
7.57%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 84%
Shared 1%
None 15%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. RPRX ranks #1 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in RPRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,090,131,227 | 43,571,633 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,135,790,017 | 55,274,069 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $1,558,104,290 | 44,163,954 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,679,145,826 | 46,604,103 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,277,258,663 | 41,029,832 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,008,480,957 | 39,532,770 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,162,101,227 | 41,078,163 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,163,798,964 | 44,133,446 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,342,897,163 | 44,217,885 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,302,091,327 | 46,354,266 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $1,306,319,165 | 48,132,615 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,457,993,921 | 47,429,861 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,706,036,997 | 47,350,458 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,946,203,178 | 49,246,032 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,016,479,945 | 50,186,161 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,166,874,904 | 51,543,171 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,085,988,056 | 53,541,788 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,240,792,994 | 56,230,690 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,071,013,937 | 57,305,311 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,082,047,737 | 50,794,041 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $2,098,917,713 | 48,118,242 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,191,093,953 | 23,798,081 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $394,053,617 | 9,366,618 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $301,261,778 | 6,205,186 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||